The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market At The End Of The 2026–2030 Forecast Period?
The deoxyribonucleic acid (dna) sequencing in drug discovery market size has experienced rapid growth in recent years. It is projected to expand from $8.46 billion in 2025 to $9.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be ascribed to elements such as increasing investment in genomic research, the expansion of pharmaceutical R&D pipelines, the availability of high-throughput sequencing platforms, a heightened focus on personalized medicine, and advancements in sequencing accuracy and speed.
The market size for deoxyribonucleic acid (dna) sequencing in drug discovery is expected to experience swift expansion over the next few years. It is projected to grow to $15.22 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This growth throughout the forecast period can be attributed to the increasing adoption of AI-driven genomic analysis, a rising demand for targeted therapeutics, the expansion of pharmacogenomics applications, the growing utilization of sequencing in early-stage drug screening, and increased collaboration between pharmaceutical and biotech firms. Key trends anticipated in the forecast period include the expanding use of next-generation sequencing in target identification, a rising embrace of single-cell sequencing approaches, the growing integration of bioinformatics in drug discovery, the broadening of precision medicine research programs, and an enhanced focus on biomarker-driven drug development.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33087&type=smp
What Drivers Are Influencing The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
The increasing need for personalized medicine is projected to fuel the expansion of deoxyribonucleic acid (DNA) sequencing within the drug discovery market moving ahead. Personalized medicine is defined as a medical approach that customizes disease prevention, diagnosis, and treatment according to an individual’s genetic makeup, lifestyle, and environmental factors. The growing demand for personalized medicine primarily arises from advancements in genomics and molecular diagnostics, which facilitate the precise identification of genetic and molecular differences among individuals, enabling treatments to be tailored for enhanced effectiveness and reduced side effects. Deoxyribonucleic acid (DNA) sequencing assists personalized medicine by detecting patient-specific genetic variations, which allows for the development of targeted therapies, optimized drug selection, and improved treatment efficacy with fewer adverse effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, an increase from six approvals in 2022. The personalized treatments newly approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the rising demand for personalized medicine is a key driver for the growth of deoxyribonucleic acid (DNA) sequencing in the drug discovery market.
What Segment Types Make Up The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
The deoxyribonucleic acid (dna) sequencing in drug discovery market covered in this report is segmented –
1) By Product Type: Instruments; Consumables
2) By Workflow: Sample Preparation; Sequencing
3) By Technology Type: Sanger Sequencing; Next-Generation Sequencing (NGS)
4) By Application: Drug Discovery; Pharmacogenomics
5) By End-User: Pharmaceutical Companies; Biotechnology Firms
Subsegments:
1) By Instruments: Sequencing Systems; Sample Preparation Systems; Detection And Imaging Systems; Automation And Robotics Systems; Data Analysis Hardware
2) By Consumables: Sequencing Reagents; Library Preparation Kits; Sample Collection Kits; Flow Cells; Quality Control Reagents
Which Market Trends Are Creating New Opportunities In The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Leading companies in the deoxyribonucleic acid (DNA) sequencing in the drug discovery market are prioritizing the creation of advanced solutions, such as high-resolution DNA methylation sequencing assays, to expedite biomarker discovery and precise drug development. High-resolution DNA methylation sequencing assays are sophisticated genomic techniques that accurately map DNA methylation at a single-base or near single-base resolution across the genome. This capability allows for an in-depth examination of epigenetic alterations that regulate gene activity, facilitating a clearer understanding of disease biology and the identification of potential drug targets. For example, in April 2025, EpiCypher Inc., a US-based epigenetics company, launched CUTANA mCUT&RUN and Multiomic CUT&RUN. These two innovative DNA methylation sequencing assays are designed to deliver high-resolution methylation profiling with considerably reduced sequencing costs and sample input requirements. Researchers can use these assays to simultaneously analyze DNA methylation and chromatin features, providing deeper multiomic insights into gene regulation mechanisms. These advancements in assays support quicker and more economical target identification and validation, thereby accelerating drug discovery and development.
Who Are The Leading Companies Operating In The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Major companies operating in the deoxyribonucleic acid (dna) sequencing in drug discovery market are Thermo Fisher Scientific Inc., Eurofins Genomics GmbH, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics, Azenta Life Sciences, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Element Biosciences Inc., Macrogen Inc., Ultima Genomics Inc., SOPHiA GENETICS SA, ProPhase Labs Inc., Singular Genomics Systems Inc., Psomagen Inc., and QitanTech Co Ltd.
Read the full deoxyribonucleic acid (dna) sequencing in drug discovery market report here:
Which Global Regions Are Shaping The Competitive Landscape Of The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
North America was the largest region in the deoxyribonucleic acid (DNA) sequencing in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) sequencing in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33087&type=smp
Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market 2026, By The Business Research Company
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Ribonucleic Acid Rna Sequencing Market Report 2026
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model